Cardiovascular risk factors and Alzheimer's disease

Current Atherosclerosis Reports

Volumn 6, Issue 4, 2004, Pages 261-266

  Luchsinger, José A ^a   Mayeux, Richard ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTIHYPERTENSIVE AGENT; HOMOCYSTEINE; HYPOCHOLESTEROLEMIC AGENT; INSULIN; LIPID; PRAVASTATIN; VITAMIN;

ALCOHOL CONSUMPTION; ALZHEIMER DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CLINICAL STUDY; CLINICAL TRIAL; DIABETES MELLITUS; DISEASE ASSOCIATION; EVIDENCE BASED MEDICINE; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERINSULINEMIA; HYPERLIPIDEMIA; HYPERTENSION; LABORATORY TEST; PREVALENCE; REVIEW; RISK FACTOR; SMOKING;

EID: 4544359508     PISSN: 15233804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11883-004-0056-z     Document Type: Review

References (48)

1. Brookmeyer R, Gray S, Kawas C: Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am J Public Health 1998, 88: 1337-1342.
2. Harris MI, Flegal KM, Cowie CC, et al.: Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care 1998, 21: 518-524.
3. Vasan RS, Beiser A, Seshadri S, et al.: Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA 2002, 287: 1003-1010.
4. Ritchie K, Lovestone S: The dementias [see comment]. Lancet 2002, 360: 1759-1766.
5. Kalaria RN: The role of cerebral ischemia in Alzheimer's disease. Neurobiol Aging 2000, 21: 321-330.
6. Breteler MM: Vascular risk factors for Alzheimer's disease: an epidemiologic perspective. Neurobiol Aging 2000, 21: 153-160.
7. Mungas D, Reed BR, Ellis WG, Jagust WJ: The effects of age on rate of progression of Alzheimer disease and dementia with associated cerebrovascular disease. Arch Neurol 2001, 58: 1243-1247.
8. Amaral DG, Insausti R: The hyppocampal formation. In The Human Nervous System. Edited by Paxinos G. San Diego: Academic Press; 1990.
9. Sacco RL, Benjamin EJ, Broderick JP, et al.: American Heart Association Prevention Conference. IV. Prevention and Rehabilitation of Stroke. Risk factors [see comment]. Stroke 1997, 28: 1507-1517.
10. Honig LS, Tang MX, Albert S, et al.: Stroke and the risk of Alzheimer disease. Arch Neurol 2003, 60: 1707-1712.
11. Vermeer SE, Prins ND, den Heijer T, et al.: Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003, 348: 1215-1222.
12. Reaven GM, Laws A: Insulin Resistance: The Metabolic Syndrome X. Totowa, New Jersey: Humana Press; 1999.
13. Park CR: Cognitive effects of insulin in the central nervous system. Neurosci Biobehav Rev 2001, 25: 311-323.
14. Watson GS, Peskind ER, Asthana S, et al.: Insulin increases CSF A(beta)42 levels in normal older adults. Neurology 2003, 60: 1899-1903.
15. Farris W, Mansourian S, Chang Y, et al.: Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci U S A 2003, 100: 4162-4167.
16. Razay G, Wilcock GK: Hyperinsulinaemia and Alzheimer's disease. Age Ageing 1994, 23: 396-399.
17. Kuusisto J, Koivisto K, Mykkanen L, et al.: Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: cross sectional population based study. BMJ 1997, 315: 1045-1049.
18. Stolk RP, Breteler MM, Ott A, et al.: Insulin and cognitive function in an elderly population. The Rotterdam Study. Diabetes Care 1997, 20: 792-795.
19. Sasaki N, Fukatsu R, Tsuzuki K et al.: Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases. Am J Pathol 1998, 153: 1149-1155.
20. Ott A, Stolk RP, van Harskamp F, et al.: Diabetes mellitus and the risk of dementia. The Rotterdam Study. Neurology 1999, 53: 1937-1042.
21. Leibson CL, Rocca WA, Hanson VA, et al.: Risk of dementia among persons with diabetes mellitus: a population- based cohort study. Am J Epidemiol 1997, 145: 301-308.
22. Luchsinger JA, Tang MX, Stern Y, et al.: Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. Am J Epidemiol 2001, 154: 635-641.
23. Peila R, Rodriguez BL, Launer LJ for the Honolulu-Asia Aging Study: Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging study. Diabetes 2002, 51: 1256-1262.
24. Stevens J, Cai J, Pamuk ER, et al.: The effect of age on the association between body-mass index and mortality [see comment]. N Engl J Med 1998, 338: 1-7.
25. Nourhashemi F, Deschamps V, Larrieu S, et al..: Body mass index and incidence of dementia: The PAQUID study. Neurology 2003, 60: 117-119.
26. Kivipelto M, Laakso MP, Tuomilehto J, et al.: Hypertension and hypercholesterolaemia as risk factors for Alzheimer's disease: potential for pharmacological intervention. CNS Drugs 2002, 16: 435-444.
27. Skoog I, Lernfelt B, Landahl S, et al.: 15-year longitudinal study of blood pressure and dementia. Lancet 1996, 347: 1141-1145.
28. Posner HB, Tang MX, Luchsinger J, et al.: The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function. Neurology 2002, 58: 1175- 1181.
29. in't Veld BA, Ruitenberg A, Hofman A, et al.: Antihypertensive drugs and incidence of dementia: the Rotterdam Study. Neurobiol Aging 2001, 22: 407-412.
30. SHEP Investigators: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA 1991, 265: 3255-3264.
31. Applegate WB, Pressel S, Wines J, et al.: Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the systolic hypertension in the elderly program. Arch Intern Med 1994, 154: 2154-2160.
32. Prince MJ, Bird AS, Blizard RA, Mann AH: Is the cognitive function of older patients affected by anti hypertensive treatment? Results from 54 months of the Medical Research Council's trial of hypertension in older adults. BMJ 1996, 312: 801-805.
33. Kivipelto M, Helkala EL, Laakso MP, et al.: Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ 2001, 322: 1447-1451.
34. Jick H, Zornberg GL, Jick SS, et al.: Statins and the risk of dementia. Lancet 2000, 356: 1627-1631.
35. Moroney JT, Tang MX, Berglund L, et al.: Low-density lipoprotein cholesterol and the risk of dementia with stroke. JAMA 1999, 282: 254-260.
36. Shepherd J, Blauw GJ, Murphy MB, et al.: Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial [see comment]. Lancet 2002, 360: 1623-1630.
37. Seshadri S, Beiser A, Selhub J, et al.: Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002, 346: 476-483.
38. Luchsinger JA, Tang MX, Shea S, et al.: Plasma homocysteine levels and risk of Alzheimer's disease. Neurology 2004, In press.
39. Breteler MM: Vascular involvement in cognitive decline and dementia. Epidemiologic evidence from the Rotterdam Study and the Rotterdam Scan Study. Ann N Y Acad Sci 2000, 903: 457-465.
40. Merchant C, Tang MX, Albert S, et al.: The influence of smoking on the risk of Alzheimer's disease [see comment]. Neurology 1999, 52: 1408-1412.
41. Belleville J: The French paradox: possible involvement of ethanol in the protective effect against cardiovascular diseases. Nutrition 2002, 18: 173-177.
42. Mukamal KJ, Koller LH, Fitzpatrick AL, et al.: Prospective study of alcohol consumption and risk of dementia in older adults. JAMA 2003, 289: 1405-1413.
43. Ruitenberg A, van Swieten JC, Witteman JC, et al.: Alcohol consumption and risk of dementia: the Rotterdam Study. Lancet 2002, 359: 281-286.
44. Truelsen T, Thudium D, Gronbaek M, for the Copenhagen City Heart Study: Amount and type of alcohol and risk of dementia: the Copenhagen City Heart Study [see comment]. Neurology 2002, 59: 1313-1319.
45. Luchsinger JA: Alcohol intake and risk of Alzheimer's disease. J Am Geriatr Soc 2004, In press.
46. Orgogozo JM, Dartigues JF, Lalont S, et al.: Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area. Rev Neurol (Paris) 1997, 153: 185-192.
47. Linday J, Laurin D, Verreault R: Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging. Am J Epidemiol 2002, 156: 445-453.
48. Kalmijn S, Foley D, White L, et al.: Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men. The Honolulu-Asia aging study. Arterioscler Thromb Vasc Biol 2000, 20: 2255-2260.